Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
September 22, 2021

Medical Devices industry cross border deals total $11.9bn globally in August 2021

Total medical devices industry cross border deals worth $11.9bn were announced globally for August 2021, with the $7.3bn private equity deal with Inovalon Holdings being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 154.9% over the previous month of $4.68bn and a rise of 77.5% when compared with the last 12-month average of $6.72bn.

In terms of number of cross border deals, the sector saw a drop of 25.00% with 33 deals in August 2021 when compared to the last 12-month average of 44 deals.

In value terms, North America led the activity with cross border deals worth $11.63bn in August 2021.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

medical devices industry cross border deals in August 2021: Top deals

The top five cross border deals accounted for 95.9% of the overall value during August 2021.

The combined value of the top five cross border deals stood at $11.44bn, against the overall value of $11.9bn recorded for the month.

The top five medical devices industry cross border deals of August 2021 tracked by GlobalData were:

1) 22C Capital,Insight Partners and Nordic Capital $7.3bn private equity deal with Inovalon Holdings

2) The $2.5bn acquisition of Smiths Medical by Trulli Bidco

3) Medtronic $1.1bn acquisition deal with Intersect ENT

4) The $340m acquisition of BioVision by Abcam

5) Amplify Partners,Anzu Partners,Genoa Ventures,Heritage Provider Network,Irving Investors,SoftBank Group and True Ventures $201m venture financing deal with InterVenn BioSciences

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy